PK INTERACTIONS BETWEEN DMPA, DEPO-PROVERA AND SELECTED PROTEASE INHIBS

DMPA、DEPO-PROVERA 和选定的蛋白酶抑制之间的 PK 相互作用

• 批准号: 7625528
• 负责人: KRISTINE B. PATTERSON
• 金额: $ 0.11万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625528
• 关键词: Affect; Anti-HIV Agents; Blood; Computer Retrieval of Information on Scientific Projects Database; Depo Provera; Endopeptidases; Funding; Grant; HIV; Institution; Peptide Hydrolases; Purpose; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The main purpose of this study is to look at the level of Depo-Provera in the blood to see if it is affected by specific kinds of anti-HIV drugs. This study will also look at the levels of HIV and anti-HIV drugs before and after receiving a shot of Depo-Provera. This study will also look at the safety of Depo-Provera and anti-HIV drugs when used together.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的主要目的是观察血液中的Depo-Provera水平，以确定它是否受到特定种类的抗艾滋病毒药物的影响。这项研究还将观察接受Depo-Provera注射前后艾滋病毒和抗艾滋病毒药物的水平。这项研究还将研究Depo-Provera和抗HIV药物一起使用时的安全性。